{
    "accession": "ENCBS328JKI",
    "age": "4",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "EFO:0003072",
    "biosample_term_name": "SK-N-SH",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [
        {
            "attachment": "/documents/716003cd-3ce7-41ce-b1e3-6f203b6632a0/@@download/attachment/ENCODE4%20_Snyder_ChIP-seq_BiorupterTruSeqProtocol_v1.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000ABD",
    "health_status": "Metastatic neuroblastoma from bone marrow",
    "lab": "Michael Snyder, Stanford",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "female",
    "source": "Michael Snyder",
    "summary": "Homo sapiens SK-N-SH cell line treated with 6 \u03bcM all-trans-retinoic acid for 48 hours",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 48,
            "duration_units": "hour",
            "treatment_term_id": "CHEBI:15367",
            "treatment_term_name": "all-trans-retinoic acid",
            "treatment_type": "chemical"
        }
    ]
}